Gene · 23210
Papers1,476
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,476
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cyclin B2 impairs the p53 signaling in nasopharyngeal carcinoma. | BMC Cancer | 2024 | 38166895 | PubTator, text mining | PubMed |
| Targeting the PHF8/YY1 axis suppresses cancer cell growth through modulation of ROS. | Proc Natl Acad Sci U S A | 2024 | 38165927 | PubTator, text mining | PubMed |
| FABP5 can substitute for androgen receptor in malignant progression of prostate cancer cells. | Int J Oncol | 2024 | 38131188 | PubTator, text mining | PubMed |
| Expanded Alternatives of CRISPR-Cas9 Applications in Immunotherapy of Colorectal Cancer. | Mol Diagn Ther | 2024 | 37907826 | PubTator, text mining | PubMed |
| Analysis of Prospective Genetic Indicators for Prenatal Exposure to Arsenic in Newborn Cord Blood of Using Machine Learning. | Biol Trace Elem Res | 2024 | 37740142 | PubTator, text mining | PubMed |
| Normative Influence of the Stars: The Relative Indirect Effects of Celebrity Exemplars on Vaping Norm Perceptions Through Liking, Parasocial Relationship Strength, and Wishful Identification. | Health Commun | 2024 | 37599262 | PubTator, text mining | PubMed |
| Development and application of an amplified luminescent proximity homogeneous assay-linked immunosorbent assay for the accurate quantification of kidney injury molecule-1. | Front Mol Biosci | 2023 | 38304229 | PubTator, text mining | PubMed |
| A prognostic model based on DNA methylation-related gene expression for predicting overall survival in hepatocellular carcinoma. | Front Oncol | 2023 | 38304027 | PubTator, text mining | PubMed |
| The utility of salivary CRP and IL-6 as a non-invasive measurement evaluated in patients with COVID-19 with and without diabetes. | F1000Res | 2023 | 38269064 | PubTator, text mining | PubMed |
| RNF5: inhibiting antiviral immunity and shaping virus life cycle. | Front Immunol | 2023 | 38250078 | PubTator, text mining | PubMed |
| Prognostic value and immune regulatory role of dynamin 1-like in lung adenocarcinoma. | Transl Lung Cancer Res | 2023 | 38205213 | PubTator, text mining | PubMed |
| Pathophysiology of Pre-Eclampsia-Two Theories of the Development of the Disease. | Int J Mol Sci | 2023 | 38203478 | PubTator, text mining | PubMed |
| Integrated control strategies for dengue, Zika, and Chikungunya virus infections. | Front Immunol | 2023 | 38196945 | PubTator, text mining | PubMed |
| Panoramic view of key cross-talks underpinning the oral squamous cell carcinoma stemness - unearthing the future opportunities. | Front Oncol | 2023 | 38170015 | PubTator, text mining | PubMed |
| Virus-Host Protein Interaction Network of the Hepatitis E Virus ORF2-4 by Mammalian Two-Hybrid Assays. | Viruses | 2023 | 38140653 | PubTator, text mining | PubMed |
| Insights into Zika Virus Pathogenesis and Potential Therapeutic Strategies. | Biomedicines | 2023 | 38137537 | PubTator, text mining | PubMed |
| Hyperactive Rac stimulates cannibalism of living target cells and enhances CAR-M-mediated cancer cell killing. | Proc Natl Acad Sci U S A | 2023 | 38109551 | PubTator, text mining | PubMed |
| An overview of the role of Niemann-pick C1 (NPC1) in viral infections and inhibition of viral infections through NPC1 inhibitor. | Cell Commun Signal | 2023 | 38098077 | PubTator, text mining | PubMed |
| Macrophage IL-1β-positive microvesicles exhibit thrombo-inflammatory properties and are detectable in patients with active juvenile idiopathic arthritis. | Front Immunol | 2023 | 38077384 | PubTator, text mining | PubMed |
| Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review. | Cancer Cell Int | 2023 | 37986065 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23210/papers?page=5